1. Home
  2. GORO vs HELP Comparison

GORO vs HELP Comparison

Compare GORO & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.01

Market Cap

207.5M

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$7.27

Market Cap

233.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GORO
HELP
Founded
1998
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.5M
233.0M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GORO
HELP
Price
$1.01
$7.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.63
$51.50
AVG Volume (30 Days)
2.7M
1.5M
Earning Date
05-07-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
91.80
N/A
EPS
0.03
N/A
Revenue
$99,759,000.00
N/A
Revenue This Year
$25.99
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
$31.26
N/A
Revenue Growth
51.78
N/A
52 Week Low
$0.43
$3.76
52 Week High
$1.87
$8.55

Technical Indicators

Market Signals
Indicator
GORO
HELP
Relative Strength Index (RSI) 30.31 71.00
Support Level $0.80 $5.77
Resistance Level $1.02 $8.55
Average True Range (ATR) 0.11 0.47
MACD -0.03 0.07
Stochastic Oscillator 10.32 91.81

Price Performance

Historical Comparison
GORO
HELP

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Companies only operating segment with a production stage property. The Companies other reporting segment is Michigan, U.S.A., with an exploration stage property.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: